Art. 11 Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 20…

Submission and assessment of applications limited to aspects covered by Part I or Part II of the assessment report

In forcesince 16 Apr 2014cited 5×

Where the sponsor so requests, the application for authorisation of a clinical trial, its assessment and the conclusion shall be limited to the aspects covered by Part I of the assessment report.

After the notification of the conclusion on the aspects covered by Part I of the assessment report, the sponsor may within two years apply for an authorisation limited to aspects covered by Part II of the assessment report. In that application the sponsor shall declare that he is not aware of any new substantial scientific information that would change the validity of any item submitted in the application on the aspects covered by Part I of the assessment report. In this case, that application shall be assessed in accordance with Article 7 and the Member State concerned shall notify its decision on the clinical trial in accordance with Article 8. In those Member States where the sponsor does not apply for an authorisation limited to aspects covered by Part II of the assessment report within two years, the application on the aspects covered by Part I of the assessment report shall be deemed to have lapsed.

  • Gesetz über den Verkehr mit Arzneimitteln40Law

    … 536/2014, auch in Verbindung mit Artikel 11 der Verordnung (EU) Nr. 536/2014, sowie nach § 40a Satz 1 Nummer 2, 3 und 5, Satz 2 und 3 und § 40b Absatz 2, 3 Satz 1, Absatz 4 Satz 1 und 9, Absatz 5 und 6 ist die Bundesoberbehörde an die …

  • Regulation (EU) 2022/2035Law

    … а) спонсорът подава досие на заявление, в съответствие с член 5 или 11 от Регламент (ЕС) № 536/2014, до повече от една държава членка за …

  • Arrêté du 5 juin 2025 relatif au montant des indemnités susceptibles d'être allouées aux…23Law

    … 1124-1 du code de la santé publique dont le dossier est soumis en deux temps conformément à l'article 11 du règlement (UE) n° 536/2014 du Parlement européen et du Conseil du 16 avril 2014 relatif aux essais de médicament, …

  • BMGBGebVLaw

  • BMGBGebVLaw

    … auf das Doppelte 2 | Genehmigung einer klinischen Prüfung bei getrennter Einreichung von Teil I und Teil II gemäß Artikel 11 der Verordnung (EU) Nr. 536/2014 nach Bewertung von Teil II | 200 unbeschadet der Gebühr nach Nummer 1.1 3 | …